Local Thermal Ablation with Continuous EGFR Tyrosine Kinase Inhibitors for EGFR-Mutant Non-small Cell Lung Cancers that Developed Extra-Central Nervous System (CNS) Oligoprogressive Disease
ConclusionLocal thermal ablation for the oligoprogressive lesions with continuous EGFR-TKI treatment is associated with additional 10 months of disease control and should be recommended in TKI acquired resistant-NSCLC patients.
Source: CardioVascular and Interventional Radiology - Category: Radiology Source Type: research
More News: Cancer | Cancer & Oncology | Cardiology | Cardiovascular | Heart | Lung Cancer | Non-Small Cell Lung Cancer | Radiology | Study